How is the new guidance different from the guidance that was issued on September 8, 2009?
The priority use for antiviral medications during the upcoming influenza season remains generally the same as outlined in the antiviral recommendations first posted on May 6, 2009 and updated on September 8, 2009; that is to prioritize use of these drugs for those patients who are severely ill (such as those who are hospitalized) and those patients who are ill with influenza-like illness and who are at higher risk for influenza related complications. New information in the updated guidance dated September 22, 2009 includes: • Additional context and guidance for clinicians regarding the risk for complications and treatment considerations for young and very young children. • Information regarding the oral dosing dispenser included in the Tamiflu® for Oral Suspension packaging and instructions to insure the units of measure on the prescription instructions match the dosing device are also included. • More information about the possible underlying physiological conditions that may be assoc
Related Questions
- With partnership bids then the risk is spread between different organisations. Is there any guidance around putting agreements in place between partners?
- Why are there different age categories on the Evaluation Guidance forms compared to the budget tables?
- Are anticipatory warrants issued at different times during the budget year?
